🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/01/2013 | 12,08 | 12,23 | 11,88 | 11,95 | -1,13% | 2,94% | 176.811 |
| 04/01/2013 | 12,46 | 12,52 | 11,97 | 12,09 | -5,09% | 4,46% | 545.661 |
| 03/01/2013 | 12,93 | 13,00 | 12,74 | 12,74 | -1,45% | 2,03% | 264.976 |
| 02/01/2013 | 13,28 | 13,36 | 12,86 | 12,93 | -0,10% | 3,76% | 432.489 |
| 31/12/2012 | 12,85 | 12,97 | 12,65 | 12,94 | +0,87% | 2,52% | 150.041 |
| 28/12/2012 | 13,31 | 13,41 | 12,83 | 12,83 | -4,51% | 4,40% | 271.869 |
| 27/12/2012 | 13,41 | 13,57 | 13,26 | 13,43 | +0,51% | 2,33% | 192.039 |
| 26/12/2012 | 13,46 | 13,47 | 13,22 | 13,36 | -0,05% | 1,85% | 177.933 |
| 24/12/2012 | 13,31 | 13,37 | 13,28 | 13,37 | +0,47% | 0,70% | 76.303 |
| 21/12/2012 | 13,26 | 13,38 | 13,10 | 13,31 | -0,79% | 2,12% | 316.432 |
| 20/12/2012 | 13,42 | 13,47 | 13,00 | 13,41 | +0,09% | 3,53% | 326.050 |
| 19/12/2012 | 13,07 | 13,44 | 12,72 | 13,40 | +3,32% | 5,54% | 607.537 |
| 18/12/2012 | 12,98 | 13,01 | 12,76 | 12,97 | -1,19% | 1,97% | 309.860 |
| 17/12/2012 | 12,51 | 13,21 | 12,40 | 13,13 | +5,52% | 6,48% | 344.805 |
| 14/12/2012 | 11,68 | 12,46 | 11,67 | 12,44 | +6,46% | 6,78% | 221.855 |
| 13/12/2012 | 11,90 | 11,94 | 11,49 | 11,68 | -1,99% | 3,78% | 65.723 |
| 12/12/2012 | 12,20 | 12,20 | 11,85 | 11,92 | -2,00% | 2,81% | 143.148 |
| 11/12/2012 | 11,95 | 12,16 | 11,90 | 12,16 | +2,90% | 2,19% | 155.010 |
| 10/12/2012 | 11,45 | 12,03 | 11,45 | 11,82 | +3,10% | 5,12% | 127.439 |
| 07/12/2012 | 11,31 | 11,57 | 11,27 | 11,47 | +1,60% | 2,70% | 185.948 |
| 06/12/2012 | 11,29 | 11,41 | 11,04 | 11,29 | +0,05% | 3,31% | 356.828 |
| 05/12/2012 | 11,73 | 11,80 | 11,08 | 11,28 | -3,47% | 6,11% | 327.653 |
| 04/12/2012 | 11,97 | 12,14 | 11,61 | 11,68 | -2,45% | 4,43% | 261.610 |
| 03/12/2012 | 12,45 | 12,46 | 11,90 | 11,98 | -2,69% | 4,51% | 138.339 |
| 30/11/2012 | 12,41 | 12,51 | 12,21 | 12,31 | -1,05% | 2,46% | 170.720 |
| 29/11/2012 | 12,21 | 12,69 | 12,21 | 12,44 | +2,05% | 3,88% | 286.937 |
| 28/11/2012 | 12,16 | 12,22 | 12,02 | 12,19 | +0,05% | 1,64% | 185.467 |
| 27/11/2012 | 12,21 | 12,28 | 12,13 | 12,18 | -0,10% | 1,23% | 276.518 |
| 26/11/2012 | 11,89 | 12,21 | 11,86 | 12,20 | +2,25% | 2,94% | 173.124 |
| 23/11/2012 | 11,95 | 11,98 | 11,82 | 11,93 | +0,26% | 1,36% | 47.449 |